Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAIR-i: Colchicine for effort-based decision making in obesity
NCT05785429Completed
- Sponsor
- Donders Centre for Cognitive Neuroimaging
- Start
- Aug 2022
- Primary completion
- Jan 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in Overweight and obesity comparing Colchicine with Placebo (2 arms). Primary endpoints: Change in effort valuation in brain and behaviour at 12 weeks and Change in reward valuation in brain and behaviour at 12 weeks. Started Aug 2022; status: completed.
02
Drugs
colchicine
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on NCT05785429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05785429.